Related references
Note: Only part of the references are listed.Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes
David Gfeller et al.
CELL SYSTEMS (2023)
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial
Linda M. Liau et al.
JAMA ONCOLOGY (2023)
Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection
Cory A. Brennick et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope
Hakimeh Ebrahimi-Nik et al.
NATURE COMMUNICATIONS (2021)
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer
Janos L. Tanyi et al.
NPJ VACCINES (2021)
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Fenge Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
Daniel J. Verdon et al.
CANCERS (2021)
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting
Julien Schmidt et al.
CELL REPORTS MEDICINE (2021)
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
Wenyan Zhong et al.
BMC GENOMICS (2020)
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Katharina Reinhard et al.
SCIENCE (2020)
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells et al.
CELL (2020)
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Actively personalized vaccination trial for newly diagnosed glioblastoma (vol 565, pg 240, 2018)
Norbert Hilf et al.
NATURE (2019)
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten et al.
ONCOIMMUNOLOGY (2019)
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
Apostolos Sarivalasis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Janos L. Tanyi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell-recognized tumor antigen T-cell epitopes
Julien Schmidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
Jon Bjoern et al.
CYTOTHERAPY (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
Morten Nielsen et al.
GENOME MEDICINE (2016)
Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
Amir-Hassan Zarnani et al.
CANCER RESEARCH AND TREATMENT (2015)
Applying Big GWAS Data to Clarify the Role of Obesity in Barrett's Esophagus and Esophageal Adenocarcinoma
Julian A. Abrams et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside
Cheryl Lai-Lai Chiang et al.
CLINICAL CANCER RESEARCH (2013)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Detecting SNPs and estimating allele frequencies in clonal bacterial populations by sequencing pooled DNA
Kathryn E. Holt et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Claus Lundegaard et al.
NUCLEIC ACIDS RESEARCH (2008)
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
FS Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma
E Gatza et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
